Your browser doesn't support javascript.
loading
Perivascular Fat: A Novel Risk Factor for Coronary Artery Disease.
Simantiris, Spyridon; Pappa, Aikaterini; Papastamos, Charalampos; Korkonikitas, Panagiotis; Antoniades, Charalambos; Tsioufis, Constantinos; Tousoulis, Dimitris.
Afiliação
  • Simantiris S; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Pappa A; Cardiology Department, Konstantopouleio General Hospital, 14233 Nea Ionia, Greece.
  • Papastamos C; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Korkonikitas P; Cardiology Department, Konstantopouleio General Hospital, 14233 Nea Ionia, Greece.
  • Antoniades C; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX1 3QT, UK.
  • Tsioufis C; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Tousoulis D; 1st Cardiology Department, Hippokration Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Diagnostics (Basel) ; 14(16)2024 Aug 22.
Article em En | MEDLINE | ID: mdl-39202318
ABSTRACT
Perivascular adipose tissue (PVAT) interacts with the vascular wall and secretes bioactive factors which regulate vascular wall physiology. Vice versa, vascular wall inflammation affects the adjacent PVAT via paracrine signals, which induce cachexia-type morphological changes in perivascular fat. These changes can be quantified in pericoronary adipose tissue (PCAT), as an increase in PCAT attenuation in coronary computed tomography angiography images. Fat attenuation index (FAI), a novel imaging biomarker, measures PCAT attenuation around coronary artery segments and is associated with coronary artery disease presence, progression, and plaque instability. Beyond its diagnostic capacity, PCAT attenuation can also ameliorate cardiac risk stratification, thus representing an innovative prognostic biomarker of cardiovascular disease (CVD). However, technical, biological, and anatomical factors are weakly related to PCAT attenuation and cause variation in its measurement. Thus, to integrate FAI, a research tool, into clinical practice, a medical device has been designed to provide FAI values standardized for these factors. In this review, we discuss the interplay of PVAT with the vascular wall, the diagnostic and prognostic value of PCAT attenuation, and its integration as a CVD risk marker in clinical practice.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Grécia País de publicação: Suíça